Browse by Tags

Sequencing The Genome of Prostate Cancer Tumors-Research To One Day Help Address Aggressive Versus Non Threatening

We normally think about sequencing our entire genome and with this study the genome of the tumor was used to compare against white blood cells from the patient. When you stop and think of all the data that has to be sifted through, it’s a lot. ...

Published Thu, Feb 02 2011 3:16 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Cancer, tumors, Prostate Cancer, Tumor, Prostate Cancer Foundation, Data, reserach and development, Seqencing

Former FDA leader von Eschenbach Named to Viamet Board of Directors

Back in September of 2010 he was also names to the Board of another technology company that deals with urology and cancer therapies. Since his tenure at the FDA it sounds like von Eschenbach is returning to his roots with using his expertise in...

Published Wed, Jan 01 2011 1:23 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Cancer, FDA, Prostate Cancer, Pharmaceuticals, National Cancer Institute, enzymes, Durham, Viamet Pharmaceuticals, drug discovery, Andrew von Eschenbach

Dendreon Announces Expanding to Europe to Seek Approval and Potential Factory in Germany

In case you are not aware, the cost of a Dendreon treatment is $93,000.00 which is not cheap by any means they anticipate upon approval that the price would be around the same in Europe. So far sales have been $48 Million and they are working on...

Published Mon, Jan 01 2011 11:20 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Prostate Cancer, Germany, Europe, Dendreon, Provenge, approval, European Union

UCLA Discovers A Process That Turns Healthy Cells into Prostate Cancer Cells–Discovery Could Lead To New Treatments

The discover was made by inhibiting a protein to slow the growth, and the findings are a result of 3 years of study. It is amazing as to what is being done with stem cells and the study here related to animals but in other research areas a prostate...

Published Fri, Dec 12 2010 1:00 AM by The Medical Quack

Filed under: Medically Related, Technology, Prostate Cancer, Research and Development, Stem Cells, Philanthropy, UCLA, Howard Hughes Medical Institute, Regenerative Medicine, UCLA’s Jonsson Cancer Center

Researchers at UCLA Discover Potential New Treatment for of Prostate Cancer When Other Methodologies Are Not Effective

The scientists found that antibodies could potentially be used to block the spread of prostate cancer in men diagnosed with this aggressive form of the castration resistant disease. These were the results published on a 4 year study and tissues...

Published Tue, Nov 11 2010 2:46 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, Prevention, Prostate Cancer, Research and Development, Stem Cells, Diagnosis, UCLA, Studies, PSA Test, UCLA Jonsson Cancer Center, basal cells

J&J Prostate Cancer Drug Found to Prolong Life for an Average of 4 Months–Competition for Provenge?

Back in 2009, Johnson and Johnson bought Cougar Biotech here in Los Angeles, who has not yet brought a product to market, but it appears from the results with the latest reports on their prostate cancer drug, it might soon be in the works for submission...

Published Mon, Oct 10 2010 3:29 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, drugs, Biotech, FDA, Congress, Prostate Cancer, Johnson and Johnson, drug manufacturers, pipeline, Cougar Biotech

FTC and FDA Tell Pom Wonderful To Change Their Advertising Claims or Submit for FDA Approval–Another Study Unrelated Claims Peaches and Plums Kill Breast Cancer Cells Too

As a blogger I have been on their list and back in April of 2009 was sent a small case of 6 bottles for me to try. This is not enough for someone like me to go out on a limb and either promote or pass on their advertising claims, stuff tastes good...

Published Mon, Sep 09 2010 7:43 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, My Commentaries, healthcare, Heart, Prostate Cancer, Diet, Breast Cancer, Dietary supplements, Pom Wonderful, Pomegranate juice, antioxidants, plums, peaches

Johnson and Johnson News: Participants With Prostate Cancer Trial Will Have Access After Completion and Company Launches Aid Program for Women and Children

Back in May of 2009, Johnson and Johnson purchased Los Angeles based Cougar Biotech who has been conducting the clinical trials for the prostate cancer drug for patients with cancer that has progressed to a serious state. Phase 3 of the studies is due...

Published Fri, Sep 09 2010 12:07 AM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, drugs, Biotech, FDA, Congress, Prostate Cancer, drug manufacturers, Follow On Biotech, pipeline, cheap drugs, Cougar Biotech, Johnson and Johnson.m HIV

CMS To Require Study For Off Label Use for Provenge to Evaluate Risk of Strokes as Well as On Label Use as Approved by FDA

The drug is just barely off and running and the treatment is not inexpensive by any means and according to this notice put out by the FDA, they want additional information at CMS on how stroke victims are affected that have received the drug so this appears...

Published Sun, Sep 09 2010 2:39 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, Biotech, FDA, Prostate Cancer, software, CMS, Algorithms, Dendreon, Provenge, off label, Intellivenge

Mix Ups In Biopsy Tests Result in Legal Cases Related to Prostate Cancer Surgeries

Both situations are sad and the man who had surgery to cure what he was told was prostate cancer is even sadder now that he lives with some not so nice side effects that came along with the surgery. In the meantime, the other man didn’t have his...

Published Sun, Aug 08 2010 3:47 AM by The Medical Quack

Filed under: Medically Related, Technology, Other Items of Interest, Surgery, Labs, healthcare, Health IT, Cancer, Hospitals, Prostate Cancer, Medical Errors, Boston, Doctors, Pathology, bar coding, time outs

Dendreon Corporation Selects Pilgrim Software As a Service Solution For Risk Management and Compliance Intelligence

Back in March I wrote about their own internal software that I believe was primarily put together for both clinical and tracking areas and now it looks like the definitive business intelligence area of reporting and compliance is added to the equation...

Published Tue, Aug 08 2010 6:14 PM by The Medical Quack

Filed under: Technology, Pharma/FDA News, Biotech, FDA, Prostate Cancer, software, Software as a Service, Algorithms, Dendreon, Provenge, Microsoft Tags, Bar Codes, Intellivenge, active cellular immunitherapy, Pilgrim

Scientists at UCLA Identify a Cell of Origin For Human Prostate Cancer – Findings Could Result in Better Diagnostic and Development of New Targeted Treatments

The current findings to be a new basis for targeting treatments for prostate cancer with the ability to create an “infected” environment, which has not been done before. At the UCLA cancer center there’s a multitude of very specific cancer research...

Published Thu, Jul 07 2010 3:00 PM by The Medical Quack

Filed under: Medically Related, Technology, Prevention, Prostate Cancer, Research and Development, Stem Cells, Diagnosis, UCLA, Studies, PSA Test, UCLA Jonsson Cancer Center, basal cells

Dendreon Announces CMS Evaluation of Provenge for Late Stage Prostate Cancer Patients

Provenge costs a total of $93,000 for the full treatment of three infusions so this was no surprise that consideration would be needed before giving a blank check for all participants of Medicare with prostate cancer who would be in a position to require...

Published Thu, Jul 07 2010 3:23 AM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, Biotech, FDA, Prostate Cancer, software, CMS, Algorithms, Dendreon, Provenge, Microsoft Tags, Bar Codes, Intellivenge, active cellular immunitherapy

Bayer Claim That Vitamins Prevent Prostate Cancer Is Now A Class Action Lawsuit – False Advertising

The FDA does not have jurisdiction over the advertisements relative to vitamin supplements, thus this fell under the area of the FTC and it sat around for a while, even with cancer researchers writing to the FTC. The attorneys are on it now and...

Published Wed, Jun 06 2010 10:37 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Lawsuit, FDA, Prostate Cancer, Advertising, Vitamins, Bayer, FTC, legal case, litigation

The Wacky World of Prostate Cancer Diagnosing and Prevention In the News– Dogs and Voices Decoding?

First up here we have dogs that are trained to smell urine and in the tests below you can see this was limited to 66 tests and the dog made 3 mistakes, not bad. This does not mean you can get a dog to replace the standard PSA test though as this...

Published Thu, Jun 06 2010 4:17 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Dogs, Prostate Cancer, chemicals, PSA Test, urine, call centers, American Urilogical Association, voice decoder, conversation

Syndication

Recent Posts

Tags

Archives